By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Norway has kicked off a national collaborative effort to use deep sequencing to discover and use genetic mutations for treating cancer patients and to create a program for using genomic medicine in the clinic.

The Norwegian Cancer Genomics Consortium will bring together regional cancer centers to create a national diagnostic service combining clinical specialists, medical genomics networks, and the Norwegian Microarray Consortium and FUGE Bioinformatics Platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.